Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Statistically significant reductions in annual exacerbation rates were seen across baseline eosinophil and exhaled FeNO level and allergy status with telepezumab, in the phase 3 NAVIGATOR trial.

Johnson & Johnson's COVID-19 vaccine is now the third vaccine to receive emergency use authorization in the US.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Treatment for severe asthma may be enhanced using an online decision support tool that draws on expert treatment decisions for a wide variety of potential patient scenarios.

AAAAI Virtual Annual Meeting. Severity of underlying airways disease and not prior use of corticosteroids posed a risk of more severe COVID-19, a new study finds.

Dupilumab therapy for 4 weeks in adults with severe atopic dermatitis resulted in significant improvements in clinical outcomes with no adverse events reported.

A new modeling study estimates that 64% of US COVID-19 hospitalizations were attributable to at least 1 of 4 pre-existing cardiometabolic conditions.

Review changes to the CDC Advisory Committee on Immunization Practices' 2021 recommended vaccination schedule for adults with this short slide-show review.

Patients with COVID-19 who have asthma share a similar risk of hospitalization with patients with the infection who do not have asthma, according to new research.

A recent survey queried cluster headache patients to compare cluster headache pain intensity to other painful disorders. The results, highlighted in this quick slideshow, may surprise.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

COVID-19 vaccination progress based on proportion of vaccines administered is currently best in New Mexico and worst in Tennessee. Find out which states are in between.

Results of a new study show that the Pfizer-BioNTech COVID-19 vaccine is 92% effective at preventing severe COVID-19 after 2 doses in over half a million study participants.

Listen to our newest podcast episode where the lead author of a recent meta-analysis shares his findings on the safety and efficacy of antidepressant medications to treat back and osteoarthritis pain.

A recent meta-analysis assessed comparative clinical efficacy of NSAIDs and COX-2 inhibitors. Try these 7 questions on the findings - does your clinical experience match?

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

AAAAI Virtual Annual Meeting. Among patients with asthma, wearing a mask, regardless of type or duration of use, had no significant effect on oxygen saturation.

Pain associated with COVID-19 has many causes and may persist after the infection has resolved. Find out what you've learned about pain in the pandemic with these 7 questions.

The FDA announced today that Johnson & Johnson's single-dose COVID-19 vaccine was found to be safe and effective against the novel disease.